Previous 10 | Next 10 |
"The merit of all things lies in their difficulty." - Alexandre Dumas, The Three Musketeers We have kicked off the second half of 2019 with the S&P 500 at all-time highs after rallying some 17% so far this year. That is the best first half of performance for the index since 1997. One...
SOUTH SAN FRANCISCO, Calif., July 02, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced...
Calithera Biosciences (NASDAQ: CALA ) is up 4.5% after hours following a filing disclosing a purchase of just over $200,000 worth of stock by the CEO's family trust. More news on: Calithera Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...
SOUTH SAN FRANCISCO, Calif., June 21, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced...
Gainers: Melinta Therapeutics (NASDAQ: MLNT ) +180% . Arcturus Therapeutics (NASDAQ: ARCT ) +37% . Hebron Technology (NASDAQ: HEBT ) +26% . MYOS RENS Technology (NASDAQ: MYOS ) +22% . Armata Pharmaceuticals (NYSEMKT: ARMP ) +19% . AquaBounty Technologies (NASDAQ: AQB ) +19% . D...
Sesen Bio (NASDAQ: SESN ) -32% on pricing equity offering. More news on: Sesen Bio, Inc., Tonix Pharmaceuticals Holding Corp., Calithera Biosciences, Inc., Stocks on the move, Read more ...
Calithera Biosciences (NASDAQ: CALA ) has priced its public offering of 12.5M common shares at $4/share, for gross proceeds of $50M. More news on: Calithera Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...
SOUTH SAN FRANCISCO, Calif., June 18, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced...
Gainers: MoneyGram International (NASDAQ: MGI ) +106% . China Internet Nationwide Financial Services (NASDAQ: CIFS ) +33% . G1 Therapeutics (NASDAQ: GTHX ) +26% . SunPower Corporation (NASDAQ: SPWR ) +24% . Sundance Energy Australia (NASDAQ: SNDE ) +20% . Cortexyme (NASDAQ: CRTX...
Digital Ally (NASDAQ: DGLY ) -42% on Axon patent win. More news on: Digital Ally, Inc., ContraVir Pharmaceuticals, Inc., Biohaven Pharmaceutical Holding Company Ltd., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Calithera Biosciences Inc. Company Name:
CALA Stock Symbol:
OTCMKTS Market:
Calithera Biosciences Inc. Website:
Williams Industrial Services Group Inc. (WLMSQ) is expected to report $-0.15 for Q3 2023 Cellcom Israel Limited (CELJF) is expected to report for quarter end 2023-09-30 Central Japan Railway Co ADR (CJPRY) is expected to report for Q2 2024 CW Petroleum Corp (CWPE) is expected to repor...
Strategic Environmental & Energy Resources Inc (SENR) is expected to report for Q1 2024 Biocept Inc. (BIOCQ) is expected to report for Q1 2024 Kalera Public Limited Company (KALRQ) is expected to report for quarter end 2023-09-30 Lanvin Group Holdings Limited (LANV) is expected to...
Murata Manufacturing Co. Ltd. ADR (MRAAY) is expected to report $0.27 for Q2 2024 Quotient Limited (QTNTQ) is expected to report for quarter end 2023-09-30 Evaxion Biotech A/S (EVAX) is expected to report for Q3 2023 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to repo...